Fatigue perception in a cohort of children with chronic immune thrombocytopenia and their caregivers using the PedsQL MFS: Real-life multicenter experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
PedsQL Multidimensional Fatigue Scale
fatigue
health-related quality of life
immune thrombocytopenia
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
pubmed:
5
12
2020
medline:
3
8
2021
entrez:
4
12
2020
Statut:
ppublish
Résumé
Fatigue is an important clinical and psychological aspect for a significant number of children affected by immune thrombocytopenia (ITP). To date, few studies have explored fatigue and its relationship with chronic ITP in pediatric age. The aim of the present multicentric pilot study is to determine fatigue perception in a large group of children with chronic ITP and their caregivers using the PedsQL Multidimensional Fatigue Scale (PedsQL MFS), and to compare the results with those of healthy control subjects. Children with chronic ITP aged 5-18 years and/or caregivers of children aged 2-18 years were enrolled. Child/adolescent self-report was used for patients aged 5-18 years, and parent proxy-report for patients aged 2-18 years. The questionnaire was offered as online survey. PedsQL MFS is composed of 18 items covering three dimensions: General Fatigue Scale, Sleep/Rest Fatigue Scale, and Cognitive Fatigue Scale. One hundred ninety-one patients affected by chronic ITP and 248 caregivers answered the PedsQL MFS. We have highlighted that lower values of PedsQL MFS scores are obtained in the 13-18 age group. Moreover, sleep/rest fatigue domain appears to be more compromised in all age groups. For all PedsQL MFS scores, pediatric patients with chronic ITP and their caregivers reported statistically significant worse fatigue than healthy children. This study suggests that fatigue is relevant among children and adolescents affected by chronic ITP. The PedsQL MFS represents an adequate instrument for measuring fatigue in patients with chronic ITP. Therefore, symptoms of fatigue should be routinely assessed in clinical practice.
Sections du résumé
BACKGROUND
Fatigue is an important clinical and psychological aspect for a significant number of children affected by immune thrombocytopenia (ITP). To date, few studies have explored fatigue and its relationship with chronic ITP in pediatric age. The aim of the present multicentric pilot study is to determine fatigue perception in a large group of children with chronic ITP and their caregivers using the PedsQL Multidimensional Fatigue Scale (PedsQL MFS), and to compare the results with those of healthy control subjects.
PROCEDURE
Children with chronic ITP aged 5-18 years and/or caregivers of children aged 2-18 years were enrolled. Child/adolescent self-report was used for patients aged 5-18 years, and parent proxy-report for patients aged 2-18 years. The questionnaire was offered as online survey. PedsQL MFS is composed of 18 items covering three dimensions: General Fatigue Scale, Sleep/Rest Fatigue Scale, and Cognitive Fatigue Scale.
RESULTS
One hundred ninety-one patients affected by chronic ITP and 248 caregivers answered the PedsQL MFS. We have highlighted that lower values of PedsQL MFS scores are obtained in the 13-18 age group. Moreover, sleep/rest fatigue domain appears to be more compromised in all age groups. For all PedsQL MFS scores, pediatric patients with chronic ITP and their caregivers reported statistically significant worse fatigue than healthy children.
CONCLUSIONS
This study suggests that fatigue is relevant among children and adolescents affected by chronic ITP. The PedsQL MFS represents an adequate instrument for measuring fatigue in patients with chronic ITP. Therefore, symptoms of fatigue should be routinely assessed in clinical practice.
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e28840Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386-2393.
Del Vecchio GC, De Santis A, Giordano P, et al. Management of acute childhood idiopathic thrombocytopenic purpura according to AIEOP consensus guidelines: assessment of Italian experience. Acta Haematol. 2008;119:1-7.
Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3:3780-3817.
Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017;6:16.
Del Vecchio GC, Penza R, Altomare M, et al. Cytokine pattern and endothelium damage markers in Henoch-Schönlein purpura. Immunopharmacol Immunotoxicol. 2008;30:623-629.
Giordano P, Cascioli S, Lassandro G, et al. B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy. Pediatr Res. 2016;79:262-270.
Giordano P, Lassandro G, Barone A, et al. Use of eltrombopag in children with chronic immune thrombocytopenia (ITP): a real life retrospective multicenter experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Front Med (Lausanne). 2020;7:66.
Giordano P, Urbano F, Lassandro G, et al. Role of antithyroid autoimmunity as a predictive biomarker of chronic immune thrombocytopenia. Pediatr Blood Cancer. 2019;66:e27452.
Parodi E, Russo G, Farruggia P, et al. Management strategies for newly diagnosed immune thrombocytopenia in Italian AIEOP centres: do we overtreat? Data from a multicentre, prospective cohort study. Blood Transfus. 2020;18:396-405.
Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol. 2010;85:174-180.
Del Vecchio GC, De Santis A, Accettura L, De Mattia D, Giordano P. Chronic immune thrombocytopenia in childhood. Blood Coagul Fibrinolysis. 2014;25:297-299.
De Mattia D, Del Vecchio GC, Russo G, et al. Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines. Acta Haematol. 2010;123:96-109.
Evim MS, Baytan B, Güneş AM. Childhood immune thrombocytopenia: long-term follow-up data evaluated by the criteria of the International Working Group on Immune Thrombocytopenic Purpura. Turk J Haematol. 2014;31:32-39.
Heitink-Pollé KM, Nijsten J, Boonacker CW, de Haas M, Bruin MC. Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis. Blood. 2014;124:3295-3307.
Flores A, Klaassen RJ, Buchanan GR, Neunert CE. Patterns and influences in health-related quality of life in children with immune thrombocytopenia: a study from the Dallas ITP Cohort. Pediatr Blood Cancer. 2017;64(8):e26405.
Giordano P, Lassandro G, di Meo NA, et al. Corrigendum: a narrative approach to describe QoL in children with chronic ITP. Front Pediatr. 2019;7:344.
Mathias SD, Gao SK, Miller KL, et al. Impact of chronic immune thrombocytopenic purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes. 2008;6:13.
Lassandro G, Palmieri VV, Palladino V, Accettura D, Valente R, Giordano P. Sport and children with immune thrombocytopenia: never give up. Curr Sports Med Rep. 2019;18:317-318.
Yang R, Yao H, Lin L, Ji JM, Shen Q. Health-related quality of life and burden of fatigue in Chinese patients with immune thrombocytopenia: a cross-sectional study. Indian J Hematol Blood Transfus. 2020;36:104-111.
Towner S, Berger ZE, Titman P, et al. Fatigue, executive function and psychological effects in children with immune thrombocytopenia: a cross-sectional study. Br J Haematol. 2020;189:534-542.
Grace RF, Klaassen RJ, Shimano KA, et al. Fatigue in children and adolescents with immune thrombocytopenia. Br J Haematol. 2020;191:98-106.
Hill QA, Newland AC. Fatigue in immune thrombocytopenia. Br J Haematol. 2015;170:141-149.
Klaassen RJ, Blanchette V, Burke TA, et al. Quality of life in childhood immune thrombocytopenia: international validation of the kids’ ITP tools. Pediatr Blood Cancer. 2013;60:95-100.
Strullu M, Rakotonjanahary J, Tarral E, et al. Evaluation of health related quality of life in children with immune thrombocytopenia with the PedsQL 4.0 Generic Core Scales: a study on behalf of the pays de Loire pediatric hematology network. Health Qual Life Outcomes. 2013;11:193.
Giordano P, Lassandro G, Giona F, et al. ITP-QoL questionnaire for children with immune thrombocytopenia: Italian version validation's. Pediatr Hematol Oncol. 2014;31:534-547.
Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer. 2002;94:2090-2106.
Varni JW, Burwinkle TM, Szer IS. The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology: reliability and validity. J Rheumatol. 2004;31:2494-2500.
Ridao-Manonellas S, Fábregas-Bofill A, Núñez-Rueda G, et al. Health-related quality of life and Multidimensional Fatigue Scale in children with primary immunodeficiencies. J Clin Immunol. 2020;40:602-609.
Steur LMH, Kaspers GJL, van Someren EJW, et al. The impact of maintenance therapy on sleep-wake rhythms and cancer-related fatigue in pediatric acute lymphoblastic leukemia. Support Care Cancer. 2020. https://doi.org/10.1007/s00520-020-05444-7
Vassallo G, Mughal Z, Robinson L, et al. Perceived fatigue in children and young adults with neurofibromatosis type 1. J Paediatr Child Health. 2020;56:878-883.
Sarpatwari A, Watson S, Erqou S, et al. Health-related lifestyle in adults and children with primary immune thrombocytopenia (ITP). Br J Haematol. 2010;151:189-191.
Panepinto JA, Torres S, Bendo CB, et al. PedsQL Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity. Pediatr Blood Cancer. 2014;61:171-177.
Varni JW, Limbers CA, Bryant WP, Wilson DP. The PedsQL multidimensional fatigue scale in pediatric obesity: feasibility, reliability and validity. Int J Pediatr Obes. 2010;5:34-42.
Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrik. 1951;16:297-334.
Nunnally JC, Bernstein IR. Psychometric Theory. New York: McGraw-Hill; 1994.
Blatt J, Weston B, Gold S. Fatigue as marker of thrombocytopenia in childhood idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol. 2010;27:65-67.
Efficace F, Mandelli F, Fazi P, et al. Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease. Am J Hematol. 2016;91:995-1001.
Newton JL, Reese JA, Watson SI, et al. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011;86:420-429.
Signorovitch J, Brainsky A, Grotzinger KM. Validation of the FACIT-fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia. Qual Life Res. 2011;20:1737-1744.
Eiser C, Morse R. Quality-of-life measures in chronic diseases of childhood. Health Technol Assess. 2001;5:1-157.
Marconi C, Di Buduo CA, LeVine K, et al. Loss-of-function mutations in PTPRJ cause a new form of inherited thrombocytopenia. Blood. 2019;133:1346-1357.
Peshko D, Kulbachinskaya E, Korsunskiy I, et al. Health-related quality of life in children and adults with primary immunodeficiencies: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2019;7:1929-1957.
Lassandro G, Palladino V, Palmieri VV, Amoruso A, Del Vecchio GC, Giordano P. Covid-19 and children with immune thrombocytopenia: emerging issues. Mediterr J Hematol Infect Dis. 2020;12:e2020028.
Nap-van der Vlist MM, Dalmeijer GW, Grootenhuis MA, et al. Fatigue in childhood chronic disease. Arch Dis Child. 2019;104:1090-1095.
ter Wolbeek M, van Doornen LJ, Kavelaars A, Heijnen CJ. Predictors of persistent and new-onset fatigue in adolescent girls. Pediatrics. 2008;121:e449-e457.
Faienza MF, Acquafredda A, Tesse R, et al. Risk factors for subclinical atherosclerosis in diabetic and obese children. Int J Med Sci. 2013;10:338-343.